Related Experiment Videos
Pleiotropic and epistatic effects in sickle cell anemia
1Division of Hematology, Albert Einstein College of Medicine/Montefiore Medical Center, The Bronx, New York 10461, USA.
Current Opinion in Hematology
|February 27, 2001
Summary
Sickle cell anemia, initially a model monogenic disease, is increasingly understood as multigenic. Genetic variations influence disease severity, paving the way for personalized medicine approaches.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Sickle cell anemia was the first described monogenic disease, establishing the concept of molecular disease.
- Phenotypically, sickle cell anemia exhibits complex traits influenced by multiple genes, not solely the sickle globin gene mutation.
Purpose of the Study:
- To explore the multigenic nature of sickle cell anemia.
- To understand how genetic variations contribute to interindividual differences in disease severity.
Main Methods:
- Review of established and potential epistatic and pleiotropic genes.
- Discussion of emerging technologies like CHIP technology and high-throughput sequencing.
Main Results:
- Identified numerous epistatic and pleiotropic genes contributing to sickle cell anemia's phenotype.
- Highlighted the role of these genes in explaining significant interindividual variability in disease severity.
Conclusions:
- Sickle cell anemia is a multigenic disease, with genetic modifiers significantly impacting clinical presentation.
- Advancements in genetic technologies will accelerate a comprehensive multigenic understanding, enabling individualized treatment strategies.